Dr. Girnius is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10506A Montgomery Rd
Montgomery, OH 45242Phone+1 513-853-1300Fax+1 513-451-4118
Education & Training
- Boston University Medical CenterResidency, Internal Medicine, 2006 - 2009
- University of Cincinnati College of MedicineClass of 2006
Certifications & Licensure
- OH State Medical License 2013 - 2025
- MA State Medical License 2008 - 2013
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study Of TAK-981 Given With Monoclonal Antibodies (mAbs) In Adults With Relapsed or Refractory Multiple Myeloma (RRMM) Start of enrollment: 2021 Apr 20
Roles: Principal Investigator
Publications & Presentations
PubMed
- 70 citationsHispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR r...Jeffrey Schriber, Parameswaran Hari, Kwang Woo Ahn, Mingwei Fei, Luciano J. Costa
Cancer. 2017-08-15 - 23 citationsHepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis associated liver disease.Saulius Girnius, David C. Seldin, Martha Skinner, Kathleen T. Finn, Karen Quillen
Haematologica. 2009-07-01 - 11 citationsBleeding and thrombotic risk in pregnant women with Fontan physiologyAndrea Girnius, Dominica Zentner, Anne Marie Valente, Petronella G. Pieper, Katherine E. Economy
Heart. 2021-09-01
Abstracts/Posters
- Long-Term Proteasome Inhibitor (PI) Therapy in Community Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Transitioning from Bortezomib (Btz)-Based to Ixazo...Saulius K. Girnius, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Genomic Landscape of Sex Disparities in Multiple MyelomaSaulius K. Girnius, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Primary Plasma Cell Leukemia Outcomes Remain Dismal Despite Novel Agents and Hematopoietic Cell TransplantationSaulius K. Girnius, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: